Drugs / ISOPENTYL 2-CYANOACRYLATE
ISOPENTYL 2-CYANOACRYLATE
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02698644 | Jan → Jul 2016 | fallopian tube disorder | Ain Shams University | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02977234 | Oct 2016 → Jan 2018 | female infertility, hydrosalpinx | Ain Shams University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06130072 Comparator | Nov 2023 → Mar 2024 | — | Ain Shams University | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ISOPENTYL 2-CYANOACRYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297394 ↗ |
| Known as | AMCRYLATE | “Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx” NCT02977234 ↗ |
| Known as | Iso-Amyl 2-Cyano Acrylate | “Hysteroscopic Tubal Occlusion Using Iso-amyl- 2-cyanoacrylate With or Without Ethiodized Oil (Lipidol) in Patients With Hydrosalpinx Prior to IVF” NCT06130072 ↗4“Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx” NCT02977234 ↗ |
| Modality | Small molecule | — CHEMBL4297394 ↗ |
| Route | Other | “injected inside fallopian tube hysteroscopically” NCT02698644 ↗ |